AIDS Treatment News - 1994
- AIDS Treatment News - 1994
- Issue #190
- 1994 Outlook
- Clarithromycin (Biaxin) Formally Approved for MAC
- Medical Marijuana: National Press Coverage, No News
- Research Strategy Proposal: High-Tech Exploitation of the Unexpected
- Major Antiviral Conference Surveys AIDS Research
- CMV Retinitis: New Trial of HPMPC As First Treatment
- Acyclovir-Resistant Herpes: Trial of Topical HPMPC
- AIDS Private Funding: New Survey Published
- Barbara McClintock Project to Cure AIDS: Strategy Session, Saturday January 22, Washington D.C.
- Trimetrexate (NeuTrexin) Approved for Pneumocystis
- Issue #191
- International Year of Decision: Interview with Paul Boneberg of Global AIDS Action Network
- Tenth International Conference on AIDS, Yokohama, August 7-12: Abstract Submission; Scholarship Information
- New York City, Philadelphia, Pittsburgh, Sherman Oaks, Stony Brook: Important Protease Trial Recruiting
- Computer Access to Treatment Information
- Primary HIV Infection, and the Immune Response
- Issue #192
- California Drug Assistance Program Adds New Medications
- AIDS Research Databases Now Free to Community Organizations, Public Libraries, and Individuals
- HIV-Infected Health Care Workers: New Legal Guide Available
- Prevention Funding: No New Dollars in President's Budget for 1995
- New California Law Requires Off-Label Coverage
- LTR Inhibitors, a New Kind of Potential AIDS Treatment: Interview with Arthur B. Pardee, Ph.D.
- Issue #193
- Correction: California AIDS Drug Assistance List
- Major Proteinase Inhibitor Trials to Begin
- Rheumatoid Arthritis Advance May Be Relevant to AIDS
- Office of AIDS Research Director Appointed
- "Living Benefits" -- Options and Resources
- National Task Force Appointed
- San Francisco: Phase I Trial of Bucast (Castanospermine Analog) Recruiting
- Issue #194
- AZT May Reduce the Risk of Maternal Transmission of HIV
- Thymosin Alpha 1: Sustained T-Helper Count Rise in Three-Drug Combination
- Merck Protease Inhibitor: Viral Resistance Suspected, Large Trials on Hold
- Isis 5320: New Combinatorial Approach to Drug Development
- Issue #195
- FDA Holds Buyers' Club Drugs: Review of Access Issues
- DOX-SL (Doxil) Kaposi's Sarcoma Treatment: Trials, Development Status
- Kaposi's Sarcoma (KS): Angiogenesis Inhibitors in Early Trials
- California: AIDS Drug Assistance Program, New Drugs Available April 1
- Issue #196
- National Task Force Meets April 14-15
- More on LTR Inhibitors: No Drug Resistance to a Tat Inhibitor
- New Nation-Wide Trial Tests Timing of Switch from AZT
- Kaposi's Sarcoma, Genistein, and Soybeans
- AIDS Hotlines: Selected List
- Issue #197
- Topotecan, CPT-11 (Irinotecan), Camptothecin, and Other Topoisomerase I Inhibitors
- Itchy Skin in HIV
- Announcements
- Issue #198
- Curcumin Trial Results: Antiviral Effect Reported
- Acyclovir Over the Counter? FDA Hearing, May 19
- d4T Approval: FDA Advisory Committee Meeting, May 20
- AIDS TREATMENT NEWS Volume III Now Available
- Resources: Drug Development: Interview with Roy Vagelos, Chairman of Merck & Co.
- Resources: Protease Inhibitors: Current Status
- Issue #199
- AIDS Research Direction: New Scientific Approach?
- AIDS TREATMENT NEWS Issue #199, May 20, 1994
- Resources - Antiviral Agents Bulletin
- Resources - New Directory of Federal Biomedical Research
- Announcements: "Poppers" Meeting, May 23-24, Gaithersburg, Maryland
- Resources - Gene Therapy Review
- San Francisco, Other Cities: Protease Inhibitor Combination Trial
- Issue #200
- D4T (Stavudine): Approval Recommended
- Government AIDS Research: the ACTG. Interview with Michael S. Saag, M.D.
- Antivirals and Immune Recovery: Interview with Michael S. Saag, M.D.
- Issue #201
- Roche Protease (Proteinase) Combination Trial: Triple Combination Results
- Merck Protease Inhibitor Combination Trial:
- AIDS Research Strategy: Rapid, Small Trials for Promising Treatment Leads
- PML Treatment Update, Peptide T Possibility
- International Issues -- Newsletter Available
- Issue #202
- Thymomodulin
- Thymomodulin Bibliography
- Zerit (d4T) Approved
- Thymopentin (TP-5) Trial Starting, 34 U.S. Cities
- Issue #203
- Interview, Kristine Gebbie, Outgoing Policy Coordinator
- Thymomodulin Warning
- Immunology Book Recommended
- Phenytoin (Dilantin) as Antiretroviral Treatment -- Negative Report?
- Zerit (d4T) Delayed; Parallel Track Extended
- Gebbie and Grassroots: Toward a Mass-Movement Organizing Style
- Yokohama International Conference: Free Interactive Video Teleconference on Aug. 9 & 11, Ten U.S. Cities
- HIV and Anal Cancer: Anal Pap Smears, Early Treatment, Recommended for High-Risk Men & Women
- Issue #204
- Nutrition and AIDS: Interview with Kristin Weaver, Bay Area Nutrition Counseling Center and Clinic (BANC), at San Francis
- California: MediCal Cut in Monthly Prescription Allowances Starting Oct. 1
- Correction -- Zerit (d4T) Information Number
- HIV RNA: New Blood Test for Individualized Therapy and Faster Trials
- Interim AIDS Coordinator Announced
- Kaposi's Sarcoma -- Major Overview Published
- Medical Marijuana: 89 Percent Support
- Issue #205
- Major FDA Public Meeting on Early Access, Accelerated Approval, September 12-13
- Human Growth Hormone Reverses Wasting in Clinical Trial
- BARRON'S: "Do We Have Too Many Drugs for AIDS?"
- Yokohama Conference Overview
- Nutrition and AIDS: Interview with Kristin Weaver (Part 2)
- Issue #206
- Accelerated Approval: Statement to FDA
- Why AIDS Drug Development Has Failed
- AIDS Pathogenesis -- New Understanding
- Announcements: AIDS Medicine & Miracles -- Seventh Annual Conference, Boulder, Colorado, September 29 - October 2
- Announcements: Cryptosporidiosis: Los Angeles Trial of Garlic Extract
- Announcements: HIV Infection in Women Conference, February 22-24, 1995
- Announcements: Paris Global Summit on AIDS, December 1 -- Action Alert, More U.S. Effort Needed
- Announcements: San Francisco: Personal Survival Strategies, September 28
- Announcements: SEARCH Alliance Seeks Medical Director
- Announcements: Yokohama Overview: List of Topics Available
- California AIDS Legislation -- Action Alerts
- Issue #207
- New Cell Transfer, Gene Therapy Grants
- AZT, Perinatal Transmission: Unanswered Questions
- "Access" and "Answers": FDA Antiviral Advisory Meeting, September 12-13
- Issue #208
- California (and Beyond): Proposition 187 and Public Health
- KS: DOX-SL Submitted for Approval
- AIDS and Nutrition: Clarification, Additional Resources
- Yokohama Conference: Behind U.S. Media Coverage
- FDA Proposes Financial Disclosure for Clinical Researchers
- Grassroots Organizing: Communication Groups
- Patents and Biotechnology: Federal Hearings October 17 in San Diego, Comments Invited
- AIDS Drug Interactions Guide Available
- Issue #209
- Protease Inhibitor: Stanford High-Dose Trial Still Enrolling
- Human Growth Hormone Available through Canada
- Passive Hyperimmune Therapy: Apparent Patient Benefit
- Alternative Treatment Research Center Receives NIH Grant
- "Surrogate Markers": Current Status, Future Directions (Part I)
- Maternal Transmission and Viral Load
- Issue #210
- HIV RNA -- Time to Wake Up and Save Lives
- Human Growth Hormone -- Canadian Number Disconnected for U.S. Calls
- California: AIDS Drug Assistance Program, New Drugs Proposed; Title II Public Input Sought
- New AIDS Treatment Information Service, 800/HIV-0440
- AIDS Patents Now Available Free through Internet
- Drugs for Infants and Children: Call for Reform
- Title II National Organization Formed
- Global AIDS Summit, Paris, December 1
- Protease Inhibitors -- Task Force Proposed
- Searle Abandons Its Protease Inhibitor
- Issue #211
- Nevirapine Triple Combination: Preliminary Results Released Nov. 17
- Viral Load, Small Trials, and Immune Recovery
- Hydroxyurea: Call for Information
- The Elections: What AIDS Organizations Need to Do Now. Interview with Tom Sheridan, Sheridan Associates
- AIDS TREATMENT NEWS Talent Search: Board Members for Charitable, Internet Work
- Strategy of Hope: Small, Rapid Viral-Load Trials
- Issue #212
- Untold History: Activism and Growth Hormone
- 3TC Plus AZT: Important Treatment Advance?
- Computer Communication for AIDS Agencies -- HandsNet AIDS/HIV Forum
- Threats to Ryan White, AIDS Funding: Call for Information
- Vpr -- A Viral Protein is Found to Activate HIV
- Issue #213
- Kaposi's Sarcoma (KS): Possible Virus Discovered
- Wasting Syndrome: Human Growth Hormone Becoming Available-- Treatment IND
- Kaposi's Sarcoma: DOX-SL Available to Some Patients through New Program
- ACT UP Fights for Breast Cancer Drug; Funeral Procession Vs. Genentech
- "AIDS Coffee Klatch" Grassroots Political Organizing
- The New Congress: Call for Information
- Activist Groups, Buyers' Clubs, and PWA Coalitions, U.S. and Canada
- AIDS TREATMENT NEWS Selected Index Through December 23, 1994, Issue #213
source: AIDS Treatment News
